Condition: Smokers · Former Smokers · Sponsor: Icahn School of Medicine at Mount Sinai
This is a study assessing the feasibility of performing an anti-aging intervention which is a combination of an exercise regimen, spermidine supplementation, and either rapamycin or lamivudine.
This description comes directly from the study's public registry record.
Thomas Marron, MD, PhD · (212) 824-9472 · thomas.marron@mssm.edu
Always discuss trial participation with your own doctor first.
| Mount Sinai Hospital | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07058974